For pharmacokinetic modeling of tissue physiology, there is great interest in measuring the arterial input function ͑AIF͒ from dynamic contrast-enhanced ͑DCE͒ magnetic resonance imaging ͑MRI͒ using paramagnetic contrast agents. Due to relaxation effects, the measured signal is a nonlinear function of the injected contrast agent concentration and depends on sequence parameters, system calibration, and time-of-flight effects, making it difficult to accurately measure the AIF during the first pass. Paramagnetic contrast agents also affect susceptibility and modify the magnetic field in proportion to their concentration. This information is contained in the MR signal phase which is discarded in a typical image reconstruction. However, quantifying AIF through contrast agent susceptibility induced phase changes is made difficult by the fact that the induced magnetic field is nonlocal and depends upon the contrast agent spatial distribution and thus on organ and vessel shapes. In this article, the contrast agent susceptibility was quantified through inversion of magnetic field shifts using a piece-wise constant model. Its feasibility is demonstrated by a determination of the AIF from the susceptibility-induced field changes of an intravenous bolus. After in vitro validation, a time-resolved two-dimensional ͑2D͒ gradient echo scan, triggered to diastole, was performed in vivo on the aortic arch during a bolus injection of 0.1 mmol/ kg Gd-DTPA. An approximate geometrical model of the aortic arch constructed from the magnitude images was used to calculate the spatial variation of the field associated with the bolus. In 14 subjects, Gd concentration curves were measured dynamically ͑one measurement per heart beat͒ and indirectly validated by independent 2D cine phase contrast flow rate measurements. Flow rate measurements using indicator conservation with this novel quantitative susceptibility imaging technique were found to be in good agreement with those obtained from the cine phase contrast measurements in all subjects. Contrary to techniques that rely on intensity, the accuracy of this signal phase based method is insensitive to factors influencing signal intensity such as flip angle, coil sensitivity, relaxation changes, and time-of-flight effects extending the range of pulse sequences and contrast doses for which quantitative DCE-MRI can be applied.
I. INTRODUCTION
Quantifying tracer concentration is essential for pharmacokinetic modeling to assess organ and tissue function.
1 Dynamic contrast-enhanced ͑DCE͒ techniques for MR angiography 2 or perfusion imaging [3] [4] [5] traditionally rely on blood signal intensity enhancement due to contrast agent ͑CA͒ induced T 1 shortening. T 1 mapping with inversion-recovery techniques can be applied to calculate CA concentration, but long acquisition times are required. 6 Faster techniques have been developed which model the nonlinear signal intensity behavior in the applied sequence. 7 Three-dimensional fast gradient echo sequences are commonly used for which the steady-state signal intensity can be related to concentration under multiple simplifying assumptions such as neglecting transverse relaxation for low doses. [3] [4] [5] 8 For quantification, a scan is usually performed to obtain tissue precontrast relaxation parameters, sensitivity maps, and to calibrate the flip angle. 3 However, inflow effects may modify the steady-state signal intensity making absolute CA quantification difficult when faster sequences ͓such as two-dimensional ͑2D͔͒ are employed. 3, 9 CA relaxivity may also change depending on macromolecular content making the extraction of concentration from the signal intensity curve more complex. 10 In addition, T 2 * apparent relaxation adds to the complexity of linking signal intensity to concentration.
11
The arterial input function ͑AIF͒ is critical for quantitative functional assessment. 5 The AIF measured from signal magnitude suffers from nonlinearity at typical peak concentration levels and is subject to the aforementioned sources of error.
However, paramagnetic and superparamagnetic CAs can modify blood susceptibility and shift its resonant frequency. 8 To avoid difficulties in CA concentration quantification from the signal magnitude, we utilize this frequency shift information, which is intrinsically contained in the signal phase. 12, 13 Phase mapping, as in phase-contrast ͑PC͒ velocity quantification, is advantageous as it is known to be relatively independent of parameters such as flip angle, coil sensitivity, or inflow effects. 14 Nevertheless, the field shifts induced by CA are not spatially uniform and depend on vessel or organ geometry and its orientation with respect to the external field. 15 In most in vitro and in vivo applications, simplified geometrical models are usually assumed. 12, 13, 15, 16 For example, an infinite cylinder model is commonly used to describe the geometry of major blood vessels. 15, 17 These models have been extensively validated in vitro, 12, 16, 17 and have been applied to estimate liver iron content from the shifts in portal and hepatic veins, 18 to measure global brain oxygen extraction, 19 and to differentiate veins and arteries in the peripheral vasculature. 20 A small animal study encouragingly reported approximate linearity between frequency shifts and CA concentration, but did not quantify concentration. 21 Phase-difference mapping has also been used to assess CA concentration in the mouse brain in vivo. 17 However, this study relied on the infinite cylinder model which may limit its applicability to properly aligned vessels. Furthermore, optimization of parameters such as CA dosage and image signal-to-noise ratio ͑SNR͒ may be required for precise AIF quantification, 22 while unbiased quantification also requires that CA distribution in the vasculature and vascular geometry be known. 23 With magnetic resonance imaging ͑MRI͒, the geometry of major blood vessels can be defined from the signal intensity maps and the simultaneously acquired signal phase can be used for CA quantification. Based on these principles, we describe a general technique to process CA-induced phase data to extract the concentration of CA over time as a step forward from previous works that did not fully address the issue of determining the conversion between phase shifts and concentration. 17, 22 The method proposed here can be applied to vessels or organs of arbitrary shape and to MR data acquired using a variety of pulse sequences and scan parameters and utilizes geometrical and phase information from multiple voxels to quantify CA concentration. Proof of concept is shown by quantifying the AIF with high temporal resolution using a fast gradient-echo sequence to during the first-pass of a Gd ͑gadolinium͒-bolus injection without the need for a time consuming three-dimensional ͑3D͒ scan. A geometrical model of the aortic arch is constructed from magnitude images to model the observed field shifts and is used to dynamically quantify Gd concentration. This absolute quantification technique is shown to be linear in the entire range of concentration used in vivo and insensitive to signal intensity variations.
II. THEORY II.A. Magnetic field variations induced by CAs
A paramagnetic or superparamagnetic CA modifies blood magnetic susceptibility in proportion to its concentration: ⌬͑r ជ͒ = m ͓CA͔͑r ជ͒, where r ជ is the position vector, ͓CA͔͑r ជ͒ the CA spatial distribution and m the molar susceptibility of the injected compound. 24 Neglecting diffusion effects for voxel sizes much larger than the diffusion length ͱ 2DTE ͑typically 1 -10 m͒, where D is the free diffusion coefficient and TE is the echo time, the phase blurring is negligible and can be assumed to be proportional to the local magnetic field. 
where d = ͓3 cos 2 ͑͒ −1͔ / 4͉r͉ 3 is the field component along B 0 induced by a unit magnetic dipole in spherical coordinates ͑with r as the radial position and as the angle with B 0 ͒. This relationship is briefly derived in Appendix A and shows that the effects on the field are purely linear with concentration. Nevertheless, the shifts are not spatially uniform as a result of the convolution with a dipole field.
For a given object i ͑such as an organ or vessel of interest͒ defined by its geometry G i ͑defined as the mask that is 1 inside the object, and 0 outside͒, with uniform susceptibility ⌬ i , Eq. ͑1͒ ͑see also Appendix A͒ indicates that the contribution to the field shifts of this object is given by
where the shape factor F i = G i d varies in space and can be calculated from the Maxwell equations. 25, 26 Equation ͑2͒ shows that the field shift depends on the shape of the vessel or organ that contains CA and can have effects inside as well as outside the object. Given a geometrical model of each object that contains CA ͑e.g., arteries, veins, organs͒, Eq. ͑1͒ allows the measured field shift to be written as a linear combination of the effects induced by individual objects
To quantify the change in susceptibility and concentration, the shape factors F i , or equivalently, the geometry of each object, must be known. Simplified models such as the infinite cylinder may be assumed in certain cases. More complex shapes such as the aortic arch can also be estimated from MRI intensity images. Assuming the shape factors can be estimated, the CA concentration within each object can be estimated using a linear least-squares inversion 28, 29 
͑4͒
where ͓CA͔ i denotes the CA concentration inside object i, F is a matrix containing the shape factors, and ⌬B denotes a vector containing the measured field at selected locations. We refer to this approach as quantitative susceptibility imaging ͑QSI͒. Additionally, the covariance matrix of the estimated concentrations CA 2 can be determined from the noise variance of the residual field:
29 B 2 = var͑F⌬B 0 − ⌬B͒ and by considering the noise propagation effect of a linear system
II.B. Relaxation effects on signal intensity induced by CAs
For comparison with the QSI technique, signal intensity behavior is briefly reviewed for the spoiled gradient-echo sequence ͑for more details see Ref. 3͒. In the fast exchange regime, 8 which is typically used to analyze signal intensity curves, the postcontrast relaxation rates are assumed to scale linearly with concentration: R 1 = R 1,0 + r 1 ͓CA͔, R 2 * = R 2,0 * + r 2 * ͓CA͔, where R 1,0 and R 2,0 * are the precontrast longitudinal and transverse relaxation rates and r 1 and r 2 * are the longitudinal and transverse relaxivities, respectively. Neglecting time-of-flight effects, the relative signal enhancement between the steady-state signal intensity of the reference precontrast scan S 0 and that of the postcontrast scan S can be defined as 3, 15 
where E i = exp͑−TRR i ͒ for i =1/ 1,0 and E i = exp͑−TER i * ͒ for i =2/ 2 , 0, TR is the sequence repetition time, and ␣ is the flip angle.
If transverse relaxation is neglected, concentration can be approximated on a pixel-by-pixel basis as
where log denotes the natural logarithm. For low doses a linear approximation can be used
Both signal intensity and phase analysis for a fast 2D spoiled gradient-echo sequence are evaluated here during the first pass of a CA injection.
III. MATERIALS AND METHODS
All imaging experiments were performed using a 1.5 T commercial scanner ͑GE Healthcare, Waukesha, WI͒. An eight-channel cardiac phase-array coil was used for signal reception.
III.A. In vitro experiments
A 16-mm diameter flexible vinyl tube was fixed to a flat surface with a curvature radius of 75 mm to mimic the aortic arch ͑Fig. 1͒. Tap water was pumped into the tube at a flow rate of 77.5Ϯ 2 ml/ s as determined from two exit volume measurements over a 60 s interval.
Time resolved 2D spoiled gradient-echo images were acquired every 0.6 s ͑using a simulated heart rate of 100 beats per minute͒ in the coronal plane during a Gd-DTPA bolus injection ͑Magnevist, Berlex Laboratories, Wayne, NJ͒. The bolus was injected with a power injector ͑Medrad, Pittsburgh, PA͒ for 20 s followed by a 20 s water flush. Six experiments were repeated with an injection rate varying from 0.5 to 3 ml/ s ͑by 0.5 ml/ s increment͒. Imaging parameters were: field-of-view ͑FOV͒ = 30 cm, phase FOV factor= 0.7, matrix size 128ϫ 90, slice thickness= 8 mm, bandwidth ͑BW͒ = 390 Hz/ pixel, TR/ TE= 4.7/ 2.1 ms ͑full-echo͒, flip angle ͑FA͒ = 30°, 120 time frames. The sequence also recorded the start acquisition time for each time frame so that potential loss of trigger during the long breath-hold could be compensated for during postprocessing. This acquisition will be referred to as the QSI scan.
Additionally, longitudinal and transverse relaxation rates of tap water were measured using a 2D inversion recovery spin-echo sequence with imaging parameters FOV= 15 cm, slice thickness= 1 cm, BW= 244 Hz/ pixel, TR/ TE =15 s/ 10 ms, matrix size 256ϫ 128, inversion time ͑TI͒ = 50 ms, 2, 4 s, and infinity ͑inversion pulse disabled͒, and a 203.4 ms, respectively. Mean signal intensities were measured within a region of interest and were then fitted to a three-parameter ͓M 0 − M inv exp͑−TIR 1,0 ͔͒ and a twoparameter ͓M 0 exp͑−TER 2,0 ͔͒ exponential model to estimate precontrast longitudinal and transverse relaxation rates, respectively, using nonlinear least squares. In these models, M 0 and M inv account for initial and inverted magnetizations.
III.B. In vivo experiments
The human study was approved by our local Institutional Review Board and written informed consent was obtained from each subject prior to imaging. Experiments were performed on nine healthy volunteers and five patients suspected of cardiovascular disease ͑seven males, seven females, mean age= 50Ϯ 18 years, age range 18-75 years͒. Vector electrocardiographic gating was used for cardiac synchronization.
The protocol consisted of three breath-hold scans. First, a cine PC scan was performed in a plane perpendicular to the ascending aorta during a ϳ20 s breath-hold with the following imaging parameters: FOV= 28 cm, phase FOV= 0.8, slice thickness= 8 mm, BW= 244 Hz/ pixel, TR/ TE =8/ 3.3 ms, matrix size 256ϫ 204, flip angle= 25°, 28 reconstructed cardiac phases, velocity encoding= 150 cm/ s. Next, the QSI scan of the aortic arch was performed to acquire one diastolic image per heartbeat in a plane through the aortic arch during the first-pass of a Gd-DTPA bolus injection ͑Magnevist, Berlex Laboratories, Wayne, NJ͒. Single doses ͑0.1 mmol/ kg͒ were injected with the power injector at a flow rate varying from 2 to 3 ml/ s, followed by a 20-ml-30-ml saline flush. Typical imaging parameters were: FOV= 30-40 cm, phase FOV 0.5-0.7, matrix size= 128 ϫ 64-90, slice thickness= 8 mm, BW= 390 Hz/ pixel, TR/ TE= 4.5-5 / 2-3 ms ͑full echo͒, FA= 30°, 32-48 time frames. Acquisition time for each frame was 300-448 ms. Injection and image acquisition were started simultaneously. Finally, a cine PC scan was repeated after the QSI scan. In five subjects, the QSI protocol was repeated after approximately 5 min to assess intraindividual reproducibility of the method. As clearance is relatively slow, it can safely be neglected during the acquisition time ͑Ͻ1 min͒. Additively, after 5 min, the first CA bolus is sufficiently homogeneous within blood so as not to affect the phase-difference based QSI method.
III.C. Field map calculation and CA concentration quantification
For each coil element, the raw k-space data were Fourier transformed into image space. To optimally combine signals from all coils, relative complex sensitivity maps were estimated from the sum of complex signals over all acquired time frames. For each frame, phase corrected signals from individual coils were combined using weighted linear least squares 30 where weightings were inversely proportional to the signal intensity of relative sensitivity maps. 31 A precontrast field map was estimated as the mean field value of the last ten acquired frames ͑in vitro experiment͒, or of the first three precontrast frames ͑in vivo experiment͒ to avoid contamination of the field map by recirculation. Subtracting the precontrast field obtained prior to CA injection from every frame is necessary for an accurate assessment of effects induced exclusively by the CA.
To estimate the shape factor, a simplified 3D geometrical model of the curved tube or aortic arch was constructed semiautomatically from the 2D signal intensity map summed over all acquired frames. The curved tube or aorta was manually outlined on the 2D image by selecting few points on the tube or aorta boundary. The contour was then interpolated using spline fitting. Two-dimensional Delaunay triangulation was performed on the spline points. Twodimensional triangulation was converted into a closed 3D triangular surface mesh by creating connected circles over each 2D triangle edge. Knowing the shape and its orientation with respect to B 0 , the shape factor F ͓Eq. ͑2͔͒ was calculated for each pixel within the imaged slice and inside the tube/aortic arch model using a Maxwell boundary element method on the surface mesh 25, 26 ͑see Appendix B͒. To extract concentration for each time frame, Eq. ͑4͒ was used assuming m = 326 ppm/ M at 298 K ͑in vitro͒ and 308 ppm/ M at 310 K ͑in vivo͒ for Gd 3+ . 24, 32 The residual sum-of-square was calculated as an estimate of the field measurement noise variance and then used to estimate the 95% confidence interval on the concentration by noise propagation 29 ͓Eq. ͑5͔͒. For comparison with previous approaches, 17, 22 the infinite cylinder model was applied with shape factor F =1/ 2͓cos 2 ͑͒ −1/ 3͔, where represents the orientation of the cylinder with respect to B 0 . This approach is conceptually similar: the orientation of the aorta must be evaluated which is equivalent to estimating the geometry. For a fair comparison, instead of using single voxel measurements as in previous works, information from multiple points within the aorta was combined. The mean shift within the straight part of the descending aorta was calculated and converted to concentration assuming F =1/ 3 for all points ͑the cylinder model parallel to B 0 ͒. 17 Similarly, signal enhancement ͓Eq. ͑6͔͒ was calculated using the base line intensity map from the same frames used for precontrast field estimation. The mean signal enhancement within the curved tube or aorta was calculated and contrast concentration was estimated using both nonlinear ͓Eq. ͑7͔͒ and linear ͓Eq. ͑8͔͒ approximations. The following fitting parameters were used: 
III.D. Cardiac flow rate quantification
In contrast to in vitro experiments where the dilution is controlled and thus dilution concentration known, direct dynamic measurement of CA concentration using non-MRI techniques ͑e.g., from blood extraction͒ in the aorta is practically difficult. The flow rate was quantified instead using indicator dilution principles, 33 which is an indirect in vivo validation of CA concentration. If neither loss of indicator nor recirculation occurs, flow rate can be accurately mea-sured by integrating the dilution curve ͑Stewart-Hamilton principle͒. Consequently, the first pass has to be sufficiently separated from subsequent passes. Usually, for a short bolus, a dispersion model is used to increase precision of the integration. Here, the dilution curve was fitted to a dispersion model ͑LDRW distribution, see, for example, Refs. 34 and 35͒ using nonlinear least squares, which allows timing and dispersion parameters to be extracted from the first pass of the AIF,
where M Gd is the total amount of injected Gd, f is the flow rate, is a dispersion parameter determining how much the curve is skewed, t 0 is the time dispersion starts, and is equivalent to the mean transit time. This standard model assumes a Gaussian indicator distribution around a moving average position with a linearly increasing standard deviation as a function of time. This evolution has been found to adequately model indicator-dilution curves for short boluses. 35 Note that for the in vitro experiment, flow rate was determined simply by integrating the dilution curve over the entire scan time.
The QSI analysis procedure took ϳ2 min per case, which included manual segmentation of the aorta, geometrical model construction, and fitting procedures. This was repeated six times using the same data set on one subject to determine the reproducibility of the algorithm for cardiac flow quantification. For comparison, mean cardiac flow rate was also obtained in vivo from standard processing of the PC data. 36, 37 The aorta was manually outlined on the velocity images and flow rate was calculated by integration over both space and time. Drawing the contours of the moving aorta for all 28 cardiac phases took ϳ5 min per case. BlandAltman analysis 38 was then performed to assess the agreement between the two PC scans ͑before and after injection͒ to estimate PC reproducibility, between the first PC scan and the QSI scan, and between the two QSI scans ͑in subjects were more than one was performed͒.
IV. RESULTS

IV.A. In vitro experiments
The geometrical model construction, shape factor calculation, and measurement for the QSI in vitro experiments are shown in Fig. 1 . The field in each location of the curved tube exhibited an angular dependence similar to that of an infinite straight cylinder with the same orientation as that of the curved tube in that location. Good qualitative agreement can be seen between the calculated shape factor and the measured field shifts. After an initial increase in the concentration, the concentration and the associated signal enhancement reached a stable plateau ͓Fig. 2͑a͔͒. Figure 2͑b͒ shows the measured signal enhancement plateau value as a function of imposed concentration for the different experiments. For comparison, the theoretical steady-state signal intensity for the nominal flip angle ͑30°͒ in the different models ͑linear and nonlinear with and without transverse relaxation͒ is also shown. For low concentrations, all models perform similarly. Note that only the model accounting for transverse relaxation displays saturation and closer similarity to the observed signal enhancement over the range of concentrations in these experiments.
Extracted Gd concentrations determined from QSI and signal enhancement techniques are shown in Fig. 2͑c͒ . The QSI technique provided results in excellent agreement with the measurements over the entire concentration range ͓͑Gd͔ QSI = 1.00͓Gd͔ inj + 0.12͒. Furthermore, flow rate calculated from the Stewart-Hamilton principle ͑78.4Ϯ 1.3 ml/ s, meanϮ standard deviation among the six experiments after subtraction of the injection rate͒ agreed with the calibration ͑77.5Ϯ 2 ml/ s͒. Similar results were obtained with the simplified shape model of an infinite cylinder parallel to B 0 ͓͑Gd͔ cyl = 0.97͓Gd͔ inj − 0.11͒, indicating that the model adequately approximates the shape factor in the input branches
of the phantom. In contrast, Gd concentration extracted using signal enhancement techniques was in poor agreement with the known injection values as expected for such high concentrations. The linear model was biased for small concentrations and reached a plateau for concentrations over 5 mM. The nonlinear model reached closer estimates of Gd concentration in the low concentration range ͑Ͻ5 mM͒ but was inaccurate for greater concentrations.
IV.B. In vivo experiments
Figures 3͑a͒-3͑f͒ show representative time-resolved magnitude images of the heart and the aortic arch obtained during first pass Gd injection. Prior to contrast arrival in the arch, T 2 * effects from the high Gd concentration in the neighboring superior vena cava reduced signal intensity ͓solid arrows in Figs. 3͑b͒ and 3͑c͔͒ while a distinct dipolar field pattern can be observed in the corresponding field maps ͓solid arrows in Figs. 3͑h͒ and 3͑i͔͒ . Subsequently, T 1 signal enhancement was observed in the right atrium and ventricle, followed by the pulmonary system, the left atrium and ventricle, and finally the aortic arch ͓Figs. 3͑d͒-3͑f͔͒. Interestingly, during this period, the induced field variations were primarily concentrated in the aorta ͓Figs. 3͑j͒-3͑l͔͒, supporting the single object model assumed here.
Figures 4͑a͒ and 4͑b͒ illustrates a contoured aortic arch using spline interpolation and corresponding 3D geometrical model. Note the strong similarity between the shape factor and the measured field ͓Figs. 4͑c͒ and 4͑d͔͒ during CA presence in the aorta following dilution through the pulmonary system, illustrating the effect of the convolution with the dipole field. The aorta shape factor ranged from approxi-
* effect͒ is observed due to highly concentrated CA flowing through the superior vena cava ͓͑b͒ and ͑c͔͒, associated with a large induced magnetic field with a typical dipolar pattern ͓͑h͒ and ͑i͔͒ highlighted by an arrow ͓on ͑b͒ and ͑h͔͒. A field variation is then observed in the liver resulting from flowing CA in the above right heart ͑i͒ highlighted by arrows. Ventricle blood is enhanced in ͑j͒. As the left ventricle and the aorta begin enhancing ͑d͒, the field map gets more homogeneous ͑j͒ showing that CA through the lungs has limited effects. While signal amplitude remains qualitatively the same ͓͑d͒ and ͑e͔͒, a smooth spatial variation in field is observed in the aorta that increases in amplitude ͑k͒ before decreasing again ͑l͒ as CA flows out of the volume.
FIG. 4. Geometrical model of the aorta
and shape factor estimation. ͑a͒ Manually selected points ͑red circles͒ and interpolated 2D contour of the aorta are displayed on a typical enhanced magnitude image. ͑b͒ The contour is then used to generate an approximate aortic arch 3D triangular surface mesh used for the shape factor calculation. ͑c͒ Calculated shape factor in the aorta ͑unitless͒ that compares well to the measured field map ͓͑d͒ in parts per million͔. B 0 orientation is approximately up-down. Starting from positive shifts in the ascending aorta, a spatially varying shift is observed. Field decreases in the curvature down to negative values near the carotid arteries and increases again in the descending aorta where the shift gets relatively uniform. mately 0.32 to −0.10, depending on orientation with respect to B 0 . This field map approximately corresponds to the time frame depicted in Fig. 3͑e͒ .
A typical dilution curve obtained in vivo with QSI ͑Fig. 5͒ allows depiction of the first and second passes. Compared to the QSI curve, the associated signal intensity enhancement curve shows saturation during the first pass but similar trend during the second pass. For the presented case, the signal enhancement curve was ϳ6 times smaller than the theoretical signal enhancement curve. This scaling factor was highly variable ͑0.10Ϯ 0.04 among all 14 subjects͒ as may be expected when time-of-flight effects are considered. 9 The signal enhancement saturation effect was seen in all 14 subjects at concentrations Ͼ ϳ 5 mM. The cylinder model derived concentration curve gave the same unsaturated AIF with similar shape as that obtained using the QSI technique, but with slightly smaller concentration values ͑Fig. 5͒.
Reproducibility of the QSI analysis was found to be better than 2% demonstrating that the use of magnitude images enabled robust model construction and shape factor estimation. A precise concentration measurement was obtained after the bolus reached the lungs with an estimated precision on concentration close to 0.1 mmol/ L ͓from Eq. ͑5͒, 95% confidence interval Ϯ0.2 mmol/ L͔. The flow rate measurement using Eq. ͑4͒ was found to be robust for estimating the area under the dilution curve, as modifying the interval considered for first pass, as indicated in Ref. 35 , did not significantly change the results. Time constants obtained for the 14 subjects ͑meanϮ standard deviation͒ were t 0 = 8.8Ϯ 3.2 s and = 11.1Ϯ 3.0 s. The arrival time ͑t m = 17.2Ϯ 3.5 s͒ was defined as the time from halfway through the bolus injection to the estimated mean transit time as depicted in Fig. 5 . Finally, the dispersion parameter was =9.6Ϯ 5.2.
The Bland-Altman plot ͑Fig. 6͒ exhibited no significant bias or trend between QSI and PC flow measurements, and an agreement close to 10% of the mean flow rate ͑biasϮ standard deviation of the difference: 1.3Ϯ 9.8 ml/beat͒. Consequently, the 95% limit of agreement between QSI and PC measurement was −18.3, 20.9 ml/beat of PC measurement over the range of approximately 60-140 ml/beat. PC repeatability was ϳ12% and QSI repeatability was ϳ5%. The absence of bias indicates an accurate measurement of concentration in vivo. Comparison of the cylinder model results with those from PC ͓Fig. 6͑a͔͒ indicated an average overestimation of flow rate by ϳ20% and consequently an average underestimation of concentration. It is noted that Fig. 5 presents a case where the concentration was indeed underestimated by the cylinder model as compared to the QSI result. The Bland-Altman comparison ͑graph not shown͒ indicated a similar trend with an agreement of 19.0Ϯ 18.8 ml/beat ͑biasϮ standard deviation of the difference͒ showing significant bias between techniques.
V. DISCUSSION
Accurate quantification of paramagnetic contrast agent concentration is required for assessing organ function FIG. 5 . Representative AIFs during the first passes together with associated signal enhancement E ͓Eq. ͑6͔͒. AIF obtained with the QSI ͓͑Gd͔ QSI in green͒ technique together with the dispersion model and AIF obtained assuming the infinite cylinder model ͓͑Gd͔ cyl in red͒ closely follow the same trend here. Each concentration measurement is plotted with its 95% confidence interval ͓2 CA from Eq. ͑5͔͒ After bolus injection, a small increase is obtained ͑5-10 s͒ for which the shape factor does not correctly model the field shift as indicated by the increase in the confidence interval. After the bolus reaches the aorta ͑ϳ12 s͒, the shifts were well represented by the single shape model, allowing a good depiction of the first and second passes on QSI-derived concentration curves. Signal enhancement is shown to saturate with ͓Gd͔ ͑measured with QSI͒. Neglecting time-of-flight effects, the signal enhancement should be six times greater in the steady-state signal model in this case. This indicates that signal enhancement cannot be used to estimate concentration absolutely and accurately here, contrarily to phasebased methods that exhibited a much sharper description of the first pass.
FIG. 6. QSI flow measurements. ͑a͒
Linear regression between QSI ͑Q QSI ͒ and PC ͑Q PC ͒ flow measurements ͑crosses͒ and between the infinite cylinder model ͑Q cyl , circles͒ and Q PC . QSI and PC flows exhibited good correlation with a linear regression coefficient close to unity, whereas the cylinder model had a slightly smaller correlation coefficient and overestimated flow by 23%. ͑b͒ Bland-Altman plot comparing PC and QSI. The agreement was 1.3Ϯ 9.8 ml/beat. through perfusion in healthy and pathological tissue. However, MRI signal enhancement is complicated by the nonlinear relationship with concentration and the dependence on multiple parameters such as flip angle, coil sensitivity, inflow effects, and relaxation rates. Our preliminary data show that paramagnetic contrast agent concentration can be measured rapidly in vivo with a fast 2D gradient-echo sequence using the induced magnetic field shifts. Phase-based methods were linear and precise. The presented QSI technique uses the magnitude image to estimate the shape factor and the phase to determine the concentration using a linear least-square inversion of the induced field. This technique provided accurate Gd concentration measurement within the aorta during the first pass of a Gd bolus injection, from which the AIF and cardiac output could be derived for all 14 subjects. Signal intensity enhancement analysis failed to provide absolute measurement in the concentration range obtained in vivo during first pass. As a phase-based measurement technique, QSI accuracy is expected to be relatively insensitive to the parameters that influence signal intensity such as flip angle, coil sensitivity, inflow effects, and relaxation rates. Compared to previous phase-based techniques to estimate the AIF, 17, 22 the introduction of more precise geometrical information enables improved precision in CA concentration and flow rate measurements. This improvement could be particularly important for conditions where the aorta is more tortuous or for aneurisms and stenosis.
The QSI technique has a high degree of precision and is not limited in the range of gadolinium concentration as indicated qualitatively by the smooth temporal evolution of the dilution curves, and quantitatively by the 95%-confidence intervals. Concentration measurement given by QSI was precise to ϳ0.1 mM in the range of 0 -20 mM commonly obtained in vivo. This precision is dependent on image SNR, as it is equivalent to field shift measurement precision. As shown in previous work, 22 phase-based methods require acquisition parameter optimization for AIF measurement. Here, the QSI method extends voxel-based measurement 17, 22 by combining geometrical information and phase information from multiple voxels for more accurate and precise concentration measurement. Considering measurement noise averaging, concentration precision is also approximately proportional to the square root of the number of points used for inversion, and thus on the apparent surface of the aorta in the imaging plane. Acquisition parameter optimization such as increasing TE would increase the measurement precision. Nevertheless, as usual in phase measurement, wrapping should be avoided. This limits TE to approximately 2 / ␥B 0 m ͓CA͔ max , which was close to 2.5 ms showing that parameters were optimized in the current protocol. Precision may also be affected by the choice of the imaging plane and the curved tube approximation of the aortic arch. Here, an oblique sagittal imaging plane was carefully chosen to bisect the aorta such that its shape was well represented. QSI was also found to be rather robust against manual segmentation of the aorta ͑ϳ2% variation͒. The simplified curved tube model appeared to be adequate in matching the calculated shifts with the measured field patterns. The infinite cylinder model used in previous works adequately modeled the shifts in vitro. It provided AIFs very similar to those obtained using QSI in vivo but was found to overestimate flow rates by 23% and to be less accurate. Although the infinite cylinder model may adequately estimate the shape factor in certain cases, our results show that 3D modeling improves shape factor estimation. Using high resolution 3D scans currently performed in clinical practice and more sophisticated segmentation algorithms, more elaborate geometrical models may be constructed to better describe anatomic variations and provide further improvements.
To implement the QSI technique into a DCE-MRI protocol, geometrical data can be acquired separately or within the same scan. QSI requires postprocessing to define geometrical features and to apply a simple linear fit of the phase data to compute concentration. As phase measurement is not biased by any intensity change ͑from inflow or relaxation effects͒, there is more flexibility in setting up the experimental protocol. For example, instead of acquiring successive full 3D data sets for dynamic studies, fewer slices could be acquired in an interleaved manner to obtain concentration estimates at different locations of interest simultaneously.
In DCE-MRI, a precontrast image is necessary for quantification. Similarly, for QSI a precontrast field is needed. The precontrast field that had been previously reported as being a possible major limitation for accurate susceptibility quantification 39 was not an issue here. A simple and commonly used precontrast reference scan was acquired at exactly the same location allowing extraction of the CAinduced field effects only. As usual in difference methods, motion may affect the accuracy of the field mapping. Here, low resolution images were acquired during breath-holding to minimize respiratory motion and gated to cardiac diastole to reduce cardiac motion. Furthermore, for gated scans, the assumption that flow is reproducible between cardiac cycles allows any additive motion-induced phase to be removed making the difference phase insensitive to flow.
Signal enhancement failed to provide accurate concentration in our setup. In vitro, the steady-state model reasonably accounted for Gd-induced signal enhancement indicating low Gd concentration may be accurately quantified in this manner. However, a small correction should be added to account for both the slice profile 40 and some inflow effects. 9 The curved tube was coplanar with the slice and the assumptions that flowing water is subject to a flip angle slightly less than that prescribed as well as limited inflow effects are reasonable. On the contrary, blood inflow and outflow effects are much more complex in vivo. As indicated by the small and highly variable scaling factor ͑0.10Ϯ 0.04͒, blood was likely subject to time-of-flight effects which are extremely difficult to estimate a priori. Signal intensity enhancement analysis would underestimate concentration measurement as determined by QSI analysis by a factor of ϳ10 and would be inaccurate for saturation concentrations obtained in vivo during the first passes ͑Ͼ ϳ 5 mM͒. Efficient correction techniques taking into account inflow effects have been proposed for through plane flow, 9 but they might be challenging to implement for in plane flow as evaluated here. This confirms that signal enhancement-derived concentration measurements are prone to error when using a 2D acquisition. For robust signal enhancement analysis, the signal must be at steady-state in the entire volume and consequently a 3D acquisition or inflow modeling is required, limiting the range of sequences or imaging planes usable for DCE-MRI. A practical consequence of the insensitivity of QSI to inflow effects is that a single slice can be acquired without restriction on its position and that a higher temporal resolution can be obtained to estimate the rapidly changing concentration in the first passes. QSI relies on a geometrical and functional model that accounts for the observed shifts. During the first pass, CA mixes well within the cardiac chambers and the pulmonic vasculature and rapidly flows through the aorta with fairly uniform concentration. The single shape factor used in this study can model the observed field shifts in the aorta with good approximation, indicating that contributions from neighboring organs may be neglected. For example, the CA in the small vessels surrounding the aorta has little effect and CA in the heart is likely to cause only a marginal field shift in a major portion of the aortic arch due to distance. It is worth noting that the single shape model obviously did not correctly model the field shifts immediately before CA arrival in the right heart as highly concentrated CA flows through the superior vena cava. However, this phenomenon did not affect the accuracy of AIF quantification in the aorta because the bolus injection was short enough to sufficiently separate these time frames. The Stewart-Hamilton principle requires the concentration-time curve after dilution. If a known amount of CA flows through the heart, any location downstream would be suitable for measuring concentration, even if blood flow is divided ͑e.g., here in the coronary and carotid arteries͒. Consequently, other locations to measure field shifts may be suitable, besides the aorta as demonstrated here. Measuring concentration elsewhere may additionally allow quantification of transit time and dispersion through vasculature.
The flow rate derived from the concentration measurements validated the proposed QSI technique in vivo. The agreement between QSI and PC was found to be approximately 10%, which is similar to PC repeatability and typical for cardiac output quantification techniques. 37 QSI repeatability was slightly better than PC ͑ϳ5%͒, but this difference was not significant due to the limited number of subjects. In this study, cardiac flow rate was measured with QSI with a single injected dose. In delayed-enhancement viability studies, 41 where CA is administered to the patient and no imaging is performed until about 10 min after injection, the developed single breath-hold QSI sequence could be incorporated to obtain cardiac output information traditionally obtained with PC and cine SSFP sequences. 42 Furthermore, timing parameters and analysis of the dispersion curve may provide useful clinical information for perfusion studies, as emphasized in dynamic studies. 5, 8 CA enhancement of blood and tissue signals is generally evaluated qualitatively because of the complex relationship between changes in the MR signal and changes in CA concentration due to T 1 and T 2 * relaxation, inflow effects and system calibration. Assessing accurate AIF measurement with MRI has always been a great challenge in many functional studies for perfusion measurement of the kidney, 4, 43 liver, 18, 44 lung, 45 brain, 5, 46 and heart. 21, 47 Induced signal changes are complex because they combine T 1 signal enhancement as well as T 2 and T 2 * decays. Although simple models and phantom experiments in uniform media link relaxation rates to concentration, the signal changes also depend on scan parameters 47 and are not linear in the general case. 5, 21, 44, 45, 48, 49 The problem is further complicated when partial voxels 5, 49 including multiple compartments 4 are encountered in the kidney, liver, or small vessels in the heart or brain, which may contain a very high CA concentration and change of relaxivity with macromolecular content. 10 In a fairly homogeneous organ, signal changes can be linear when low doses 4, 43, 45 and adapted acquisition parameters are used which assume valid simplified models that either neglect T 1 or T 2 * effects. Some studies reported a linear relationship of R 2 * with concentration, 21, 43, 44, 48 while others reported a quadratic 49 relationship. The large number of studies on this topic suggests that each approach has its range of validity for a given organ of interest, injection protocol, and set of acquisition parameters. The QSI approach presented here is based on geometrical and functional models and a fit to the magnetic field shifts, which is conceptually different in principle than previous T 1 or T 2 * based CA concentration measurement techniques. By using the signal phase instead of intensity, QSI is intrinsically insensitive to signal intensity variation and relaxivity change and leads to improved robustness. This approach also offers the opportunity for more quantitative analysis of CA signal enhancement, as shown here by the in vivo comparison of signal enhancement and CA concentration measured with QSI. For perfusion measurements following contrast injection 4 in which similar geometrical segmentation is performed to analyze the signal amplitude, the QSI method may be useful in quantifying AIF in large vessels and CA in organs for pharmacokinetic modeling and functional characterization. Furthermore, this approach could be applied similarly with different CA with arbitrary relaxivities. A straight forward application of this technique could be done using bolus-injectable ultrasmall superparamagnetic iron oxides 50 for which molar susceptibility is more efficient ͑ϳ3600 ppm/ M at 1.5 T͒ 51 and doses are ϳ2.5-10 times lower.
50
VI. CONCLUSION
Contrast agent concentration can be quantified using the linear susceptibility effects that modify the field measured on the signal phase. However, for accurate and precise quantification, a geometrical description of the object or organ is needed as well as an adequate functional model that accounts for the observed shifts. The geometrical description of the organ or vessels allows a more detailed shape-factor descrip-tion for accurate conversion of phase shifts to concentration and combination of multiple phase shift measurements for more precise concentration determination. During first pass of a short CA bolus injection, field shifts can be isolated by subtracting a precontrast reference scan. The shifts in the aortic arch were modeled fairly well with a single approximate shape which allowed estimation of CA concentration and the AIF. Cardiac flow rate could then be quantified in vivo leading to a practical tool that can be inserted into a perfusion cardiac protocol without increasing examination time. Relying on phase, the technique is insensitive to the multiple factors that affect signal intensity. Combined with more sophisticated models, it may be possible to adapt the QSI methods to other sites for perfusion quantification.
APPENDIX A: MAGNETOSTATIC APPROXIMATION OF MAXWELL EQUATIONS
From the magnetostatic macroscopic Maxwell equations, it follows that for a material placed in a main magnetic field
where B ជ is the magnetic field and M ជ the material magnetization. Using the vector relationship for any vector field A ជ ;
and applying it to Eq. ͑A2͒,
Looking for harmonic solutions of the form B ជ =1/ ͑2͒ 3 ͐b ជ exp͑ik ជ · r ជ͒d 3 k, we have
where k ជ is the Fourier domain position, b ជ is the Fourier transform of the local shifts, and m ជ is of the magnetization. In MRI, only the local field influences proton precession and molecular demagnetization must be taken into account. 52 This is the Lorentz-sphere correction which amounts to removing 2 / 3M ជ from the macroscopic field, or 2 / 3m ជ in the Fourier domain. This leads to the measurable shift
͑A6͒
Evaluating the Fourier integral of the previous expression, 53 it comes
Since the magnetization is mainly aligned with the main magnetic field B ជ 0 = B 0 z ជ, components orthogonal to it can be neglected resulting in the following simplification for the component along z measured with MR: We refer to the integral in this expression that corresponds to the convolution of a dipole field with the shape of the object to as the shape factor F. The field shifts for the component along the main magnetic field can then be calculated. For a given object i described by a triangular surface mesh ͑K triangles forming a closed surface͒, the unit field deformation along z ជ is given by 26, 55 F͑r ជ͒ = 1 4
͑B3͒
where n k ជ is the normal to triangle k, ⍀ k ͑r ជ͒ is the solid angle of triangle k subtended at point r ជ ͑the surface area of the projection of the triangle over a sphere of unit radius cen-tered at point r ជ͒, ⍀͑r ជ͒ = ͚ k=1 k=K ⍀ k ͑r ជ͒ is the solid angle of the closed surface subtended at point r ជ ͑its value is 4 if the point is inside the surface and 0 if outside͒. If x i ជ , i =1,2,3 are the coordinates of the triangle k vertices, the normal can be calculated via
With y i ជ = x i ជ − r ជ, i =1,2,3, the solid angle of the triangle k subtended at point r ជ is given by ͪ .
͑B5͒
Finally, the vector ⌰ k ជ ͑r ជ͒ is given by
with
͑B7͒
where subscripts are given modulo 3 to simplify the expressions. These expressions were given in Ref. 26 and are modified to include the Lorentz-sphere correction. We noticed a typo error in the previously cited paper; 26 Eq. ͑B-6͒ was copied from Ref. 55 instead. As stated by the author, this method is an explicit expression of the field shift in the case Ӷ 1. In this method, the computation time is proportional to the number of triangles and to the number of points where the field needs to be calculated. The computation time can thus be reduced if the surface mesh is optimized as the accuracy does not depend on the mesh size, and triangles that are parallel to the main magnetic field can be removed as they do not contribute to the sum ͑z ជ · n k ជ =0͒. 
